Concepedia

Stephan Urwyler

SU

Statistics

Publications

43

Citations

2.9K

H-Index

26

Active since

1980

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

University of Bern

Sanden (Japan)

Stephan Urwyler is an author at Novartis (Switzerland) specializing in medicine, pharmacology, and neuropharmacology.

Top concepts

Publications per year

1980–2016

43

Publications

43

2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist

F. Gasparini, Kurt Lingenhöhl, Natacha Stoehr et al. · Neuropharmacology · 1999 · 720 citations

, , +7

Positive allosteric modulation of native and recombinant gamma-aminobutyric acid(B) receptors by 2,6-Di-tert-butyl-4-(3-hydroxy-2,2-dimethyl-propyl)-phenol (CGP7930) and its aldehyde analog CGP13501.

Stephan Urwyler, Johannes Mosbacher, Kurt Lingenhoehl et al. · PubMed · 2001 · 239 citations

, , +15

Positive Allosteric Modulation of Native and Recombinant γ-Aminobutyric Acid<sub>B</sub>Receptors by 2,6-Di-<i>tert</i>-butyl-4-(3-hydroxy-2,2-dimethyl-propyl)-phenol (CGP7930) and its Aldehyde Analog CGP13501

Stephan Urwyler, Johannes Mosbacher, Kurt Lingenhoehl et al. · Molecular Pharmacology · 2001 · 218 citations

N,N′-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine (GS39783) and Structurally Related Compounds: Novel Allosteric Enhancers of γ-Aminobutyric AcidB Receptor Function

Stephan Urwyler, Mario F. Pozza, Kurt Lingenhoehl et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 183 citations · Full text

(R, S)-4-Phosphonophenylglycine, a Potent and Selective Group III Metabotropic Glutamate Receptor Agonist, Is Anticonvulsive and Neuroprotective In Vivo

F. Gasparini, Valeria Bruno, Giuseppe Battaglia et al. · Journal of Pharmacology and Experimental Therapeutics · 1999 · 174 citations

1–5 of 43